Knee Cartilage Defects

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

MEDIPOST
MEDIPOSTKorea - Gyeonggi
1 program
1
CARTISTEM® + DebridementPhase 31 trial
Active Trials
NCT07339111Not Yet RecruitingEst. Jun 2029

Trial Timeline

Clinical trial activity over time

2026
2027
2028
2029
MEDIPOSTCARTISTEM® + Debridement

Clinical Trials (1)

NCT07339111MEDIPOSTCARTISTEM® + Debridement

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

Start: Feb 2026Est. completion: Jun 2029
Phase 3Not Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space